International Stem Cell Corporation
ISCO
$0.18
$0.001.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.90% | 8.72% | 4.98% | 0.00% | 29.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.90% | 8.72% | 4.98% | 0.00% | 29.49% |
| Cost of Revenue | 7.68% | 7.60% | 1.53% | 11.84% | 14.72% |
| Gross Profit | -25.21% | 9.63% | 7.19% | -8.45% | 41.91% |
| SG&A Expenses | 10.93% | -3.52% | 0.42% | -6.28% | -5.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.05% | 0.26% | 4.49% | 1.60% | 3.55% |
| Operating Income | -713.73% | 204.44% | 12.08% | -20.79% | 112.03% |
| Income Before Tax | -3,263.64% | 145.60% | 8.40% | -19.63% | 102.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,263.64% | 145.60% | 8.40% | -19.63% | 102.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,263.64% | 145.60% | 8.40% | -19.63% | 102.40% |
| EBIT | -713.73% | 204.44% | 12.08% | -20.79% | 112.03% |
| EBITDA | -346.67% | 505.41% | 11.06% | -24.03% | 127.93% |
| EPS Basic | -3,207.14% | 123.08% | 9.09% | -19.85% | 103.69% |
| Normalized Basic EPS | -3,122.22% | 145.92% | 8.60% | -19.76% | 102.51% |
| EPS Diluted | -3,207.14% | 118.00% | 9.09% | -19.85% | 103.69% |
| Normalized Diluted EPS | -3,122.22% | 144.90% | 8.60% | -19.76% | 102.51% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 2.04% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |